The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
The biology and treatment of oligometastatic cancer
Open accessAbstract
// Diane K. Reyes 1 , Kenneth J. Pienta 1, 2 1 Departments of Urology and Brady Urological Institute, and Oncology, The Johns Hopkins Medical Institutions, Baltimore, MD, 21287, USA 2 Departments of Pharmacology and Molecular Sciences, and Chemical and Biomolecular Engineering, The Johns Hopkins Medical Institutions, Baltimore, MD, 21287, USA Correspondence to: Kenneth J. Pienta, e-mail: kpienta1@jhmi.edu Keywords: metastasis, therapy, tumor, spectrum theory, diaspora Received: February 06, 2015 Accepted: February 24, 2015 Published: April 13, 2015 ABSTRACT Clinical reports of limited and treatable cancer metastases, a disease state that exists in a transitional zone between localized and widespread systemic disease, were noted on occasion historically and are now termed oligometastasis. The ramification of a diagnosis of oligometastasis is a change in treatment paradigm, i.e. if the primary cancer site (if still present) is controlled, or resected, and the metastatic sites are ablated (surgically or with radiation), a prolonged disease-free interval, and perhaps even cure, may be achieved. Contemporary molecular diagnostics are edging closer to being able to determine where an individual metastatic deposit is within the continuum of malignancy. Preclinical models are on the outset of laying the groundwork for understanding the oligometastatic state. Meanwhile, in the clinic, patients are increasingly being designated as having oligometastatic disease and being treated owing to improved diagnostic imaging, novel treatment options with the potential to provide either direct or bridging therapy, and progressively broad definitions of oligometastasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., & Thun, M. J. (2009) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20006 · Cited by 9,709
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Gerlinger, M., Rowan, A. J., Horswell, S., Larkin, J., Endesfelder, D., Gronroos, E., Martinez, P., Matthews, N., Stewart, A., Tarpey, P., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113205 · Cited by 7,774
The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited
Fidler, I. J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1098 · Cited by 4,686 · cited 2×
“The rationales of discrete steps of metastases [11, 12] and the hallmarks of cancer [16, 17] have both provided a biologic framework to support the oligometastatic state.”
BackgroundThe polycomb group protein EZH2 is involved in progression of prostate cancer
Varambally, S., Dhanasekaran, S. M., Zhou, M., Barrette, T. R., Kumar-Sinha, C., Sanda, M. G., Ghosh, D., Pienta, K. J., Sewalt, R. G. A. B., Otte, A. P., et al. (2002) · Nature · doi:10.1038/nature01075 · Cited by 2,717
Self-citationHellman, S., & Weichselbaum, R. R. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.1.8 · Cited by 2,562
Breast cancer metastasis: markers and models
Weigelt, B., Peterse, J. L., & van't Veer, L. J. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1670 · Cited by 2,232
De Ruysscher, D., Wanders, R., van Baardwijk, A., Dingemans, A.-M. C., Reymen, B., Houben, R., Bootsma, G., Pitz, C., van Eijsden, L., Geraedts, W., et al. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318262caf6 · Cited by 283
Lam, V. W. T., Spiro, C., Laurence, J. M., Johnston, E., Hollands, M. J., Pleass, H. C. C., & Richardson, A. J. (2012) · Annals of Surgical Oncology · doi:10.1245/s10434-011-2061-0 · Cited by 186
Metastasectomy for synchronous solitary non-small cell lung cancer metastases
Tönnies, M., Pfannschmidt, J., Bauer, T. T., Kollmeier, J., Tönnies, S., & Kaiser, D. (2014) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2014.03.028 · Cited by 88
Welter, S., Chalvatzoulis, E., Christof, D., Theegarten, D., Stamatis, G., & Cheufou, D. (2014) · The Thoracic and Cardiovascular Surgeon · doi:10.1055/s-0034-1377060 · Cited by 20
Cited by
Rowe, S. P., Pienta, K. J., Pomper, M. G., & Gorin, M. A. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.195255 · Cited by 170
Self-citationKhatri, W., Chung, H. W., Werner, R. A., Leal, J. P., Pienta, K. J., Lodge, M. A., Gorin, M. A., Pomper, M. G., & Rowe, S. P. (2021) · Diagnostics · doi:10.3390/diagnostics11040665 · Cited by 10
Self-citation
Metadata
- Authors
- Reyes, D. K., & Pienta, K. J.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2015-04-13
- Volume
- 6
- Issue
- 11
- Pages
- 8491-8524
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W1891507428
- Cited by
- 320
- References
- 10
- FWCI
- 19.98
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The biology and treatment of oligometastatic cancer. https://app.cochat.ai/papers/10.18632/oncotarget.3455
- The paper
- Reyes, D. K., & Pienta, K. J. (2015). The biology and treatment of oligometastatic cancer. Oncotarget. https://doi.org/10.18632/oncotarget.3455
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
